Related references
Note: Only part of the references are listed.The Respiratory Syncytial Virus (RSV) G Protein Enhances the Immune Responses to the RSV F Protein in an Enveloped Virus-Like Particle Vaccine Candidate
Lori McGinnes Cullen et al.
JOURNAL OF VIROLOGY (2023)
Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis
You Li et al.
LANCET (2022)
A prefusion-stabilized RSV F subunit vaccine elicits B cell responses with greater breadth and potency than a postfusion F vaccine
Lauren A. Chang et al.
SCIENCE TRANSLATIONAL MEDICINE (2022)
Correlative outcomes of maternal immunization against RSV in cotton rats
Jorge C. G. Blanco et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2022)
Virus-like particles coexpressing the PreF and Gt antigens of respiratory syncytial virus confer protection in mice
Ki-Back Chu et al.
NANOMEDICINE (2022)
Coexpression of respiratory syncytial virus (RSV) fusion (F) protein and attachment glycoprotein (G) in a vesicular stomatitis virus (VSV) vector system provides synergistic effects against RSV infection in a cotton rat model
Kelsey A. Brakel et al.
VACCINE (2021)
In vitro model for the assessment of human immune responses to subunit RSV vaccines
Tatiana Chirkova et al.
PLOS ONE (2020)
Two RSV Platforms for G, F, or G plus F Proteins VLPs
Binh Ha et al.
VIRUSES-BASEL (2020)
Effect of Previous Respiratory Syncytial Virus Infection on Murine Immune Responses to F and G Protein-Containing Virus-Like Particles
Lori McGinnes Cullen et al.
JOURNAL OF VIROLOGY (2019)
Causes of severe pneumonia requiring hospital admission in children without HIV infection from Africa and Asia: the PERCH multi-country case-control study
Katherine L. O'Brien et al.
LANCET (2019)
Alternative Virus-Like Particle-Associated Prefusion F Proteins as Maternal Vaccines for Respiratory Syncytial Virus
Jorge C. G. Blanco et al.
JOURNAL OF VIROLOGY (2019)
Protective Immunity Induced by Incorporating Multiple Antigenic Proteins of Toxoplasma gondii Into Influenza Virus-Like Particles
Su-Hwa Lee et al.
FRONTIERS IN IMMUNOLOGY (2019)
The respiratory syncytial virus vaccine landscape: lessons from the graveyard and promising candidates
Natalie I. Mazur et al.
LANCET INFECTIOUS DISEASES (2018)
Protection induced by virus-like particle vaccine containing tandem repeat gene of respiratory syncytial virus G protein
Ah-Ra Kim et al.
PLOS ONE (2018)
Efficacy of a respiratory syncytial virus vaccine candidate in a maternal immunization model
Jorge C. G. Blanco et al.
NATURE COMMUNICATIONS (2018)
Prefusion F, Postfusion F, G Antibodies, and Disease Severity in Infants and Young Children With Acute Respiratory Syncytial Virus Infection
Cristina Capella et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study
Ting Shi et al.
LANCET (2017)
Inhalation of volatile anesthetics via a laryngeal mask is associated with lower incidence of intraoperative awareness in non-critically ill patients
Pei-Jen Kuo et al.
PLOS ONE (2017)
Protection induced by virus-like particles containing Toxoplasma gondii microneme protein 8 against highly virulent RH strain of Toxoplasma gondii infection
Su-Hwa Lee et al.
PLOS ONE (2017)
Vaccine development for respiratory syncytial virus
Barney S. Graham
CURRENT OPINION IN VIROLOGY (2017)
The importance of RSV F protein conformation in VLPs in stimulation of neutralizing antibody titers in mice previously infected with RSV
Lori M. Cullen et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2017)
Soluble F proteins exacerbate pulmonary histopathology after vaccination upon respiratory syncytial virus challenge but not when presented on virus-like particles
Youri Lee et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2017)
The Central Conserved Region (CCR) of Respiratory Syncytial Virus (RSV) G Protein Modulates Host miRNA Expression and Alters the Cellular Response to Infection
Abhijeet A. Bakre et al.
VACCINES (2017)
Brief History and Characterization of Enhanced Respiratory Syncytial Virus Disease
Patricio L. Acosta et al.
CLINICAL AND VACCINE IMMUNOLOGY (2016)
The Interaction between Respiratory Pathogens and Mucus
Mark Zanin et al.
CELL HOST & MICROBE (2016)
Evaluation of protective efficacy induced by virus-like particles containing a Trichinella spiralis excretory-secretory (ES) protein in mice
Su-Hwa Lee et al.
PARASITES & VECTORS (2016)
Virus-Like Nanoparticle Vaccine Confers Protection against Toxoplasma gondii
Dong Hun Lee et al.
PLOS ONE (2016)
Virus-like nanoparticle and DNA vaccination confers protection against respiratory syncytial virus by modulating innate and adaptive immune cells
Eun-Ju Ko et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2015)
Respiratory Syncytial Virus Can Infect Basal Cells and Alter Human Airway Epithelial Differentiation
B. David Persson et al.
PLOS ONE (2014)
Intranasal DNA Vaccine for Protection against Respiratory Infectious Diseases: The Delivery Perspectives
Yingying Xu et al.
Pharmaceutics (2014)
Analysis of naive lung CD4 T cells provides evidence of functional lung to lymph node migration
Stephane M. Caucheteux et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus
Jason S. McLellan et al.
SCIENCE (2013)
Respiratory Syncytial Virus Glycoprotein G Interacts with DC-SIGN and L-SIGN To Activate ERK1 and ERK2
Teresa R. Johnson et al.
JOURNAL OF VIROLOGY (2012)
Viruslike Particle Vaccine Induces Protection Against Respiratory Syncytial Virus Infection in Mice
Fu-Shi Quan et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Newcastle Disease Virus-Like Particles Containing Respiratory Syncytial Virus G Protein Induced Protection in BALB/c Mice, with No Evidence of Immunopathology
Matthew R. Murawski et al.
JOURNAL OF VIROLOGY (2010)
Single intranasal immunization with recombinant adenovirus-based vaccine induces protective immunity against respiratory syncytial virus infection
Jae-Rang Yu et al.
JOURNAL OF VIROLOGY (2008)
Respiratory syncytial virus (RSV) fusion protein expressed by recombinant Sendai virus elicits B-cell and T-cell responses in cotton rats and confers protection against RSV subtypes A and B
Xiaoyan Zhan et al.
VACCINE (2007)
Evidence that a significant number of naive T cells enter non-lymphoid organs as part of a normal migratory pathway
Stephen Cose et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2006)
Prokaryotic diversity -: Magnitude, dynamics, and controlling factors
V Torsvik et al.
SCIENCE (2002)
Immunopathogenesis of vaccine-enhanced RSV disease
PJM Openshaw et al.
VACCINE (2001)
Share Paper
